vs
Pioneer Bancorp, Inc.（PBFS）与Spero Therapeutics, Inc.（SPRO）财务数据对比。点击上方公司名可切换其他公司
Pioneer Bancorp, Inc.的季度营收约是Spero Therapeutics, Inc.的2.0倍（$25.0M vs $12.6M），Spero Therapeutics, Inc.净利率更高（250.7% vs 82.1%，领先168.6%），过去两年Spero Therapeutics, Inc.的营收复合增速更高（847.7% vs 144.9%）
先锋银行控股公司（马里兰州）是一家美国银行控股企业，为先锋银行的母公司，主要面向马里兰州本地社区用户提供零售及商业银行服务，涵盖存款账户、住房与商业抵押贷款、消费贷款及小微企业融资等产品。
PBFS vs SPRO — 直观对比
营收规模更大
PBFS
是对方的2.0倍
$12.6M
净利率更高
SPRO
高出168.6%
82.1%
两年增速更快
SPRO
近两年复合增速
144.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.0M | $12.6M |
| 净利润 | $3.7M | $31.5M |
| 毛利率 | — | — |
| 营业利润率 | 21.3% | — |
| 净利率 | 82.1% | 250.7% |
| 营收同比 | — | 24080.8% |
| 净利润同比 | — | 250.9% |
| 每股收益（稀释后） | $0.16 | $0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBFSSPRO
| Q4 25 | $25.0M | $12.6M | ||
| Q3 25 | $24.0M | $0 | ||
| Q2 25 | $24.4M | $0 | ||
| Q1 25 | $22.8M | $12.0K | ||
| Q4 24 | — | $52.0K | ||
| Q3 24 | $22.0M | $65.0K | ||
| Q2 24 | $20.9M | $114.0K | ||
| Q1 24 | $21.6M | $140.0K |
净利润PBFSSPRO
| Q4 25 | $3.7M | $31.5M | ||
| Q3 25 | $4.3M | $-7.4M | ||
| Q2 25 | $6.5M | $-1.7M | ||
| Q1 25 | $5.8M | $-13.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $6.3M | $-17.1M | ||
| Q2 24 | $3.9M | $-17.9M | ||
| Q1 24 | $4.7M | $-12.7M |
营业利润率PBFSSPRO
| Q4 25 | 21.3% | — | ||
| Q3 25 | 23.4% | — | ||
| Q2 25 | 33.3% | — | ||
| Q1 25 | 32.5% | -122758.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | 37.2% | -28604.6% | ||
| Q2 24 | 24.1% | -16720.2% | ||
| Q1 24 | 28.1% | -9987.1% |
净利率PBFSSPRO
| Q4 25 | 82.1% | 250.7% | ||
| Q3 25 | 18.0% | — | ||
| Q2 25 | 26.4% | — | ||
| Q1 25 | 25.3% | -115550.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | 28.7% | -26380.0% | ||
| Q2 24 | 107.4% | -15668.4% | ||
| Q1 24 | 21.9% | -9049.3% |
每股收益（稀释后）PBFSSPRO
| Q4 25 | $0.16 | $0.56 | ||
| Q3 25 | $0.18 | $-0.13 | ||
| Q2 25 | $0.26 | $-0.03 | ||
| Q1 25 | $0.23 | $-0.25 | ||
| Q4 24 | — | — | ||
| Q3 24 | $0.25 | $-0.32 | ||
| Q2 24 | $0.15 | $-0.33 | ||
| Q1 24 | $0.19 | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $40.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $323.9M | $59.0M |
| 总资产 | $2.2B | $68.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PBFSSPRO
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | — | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
股东权益PBFSSPRO
| Q4 25 | $323.9M | $59.0M | ||
| Q3 25 | $314.2M | $26.5M | ||
| Q2 25 | $314.2M | $32.8M | ||
| Q1 25 | $310.7M | $33.8M | ||
| Q4 24 | — | $46.1M | ||
| Q3 24 | $303.8M | $65.5M | ||
| Q2 24 | $296.5M | $80.5M | ||
| Q1 24 | $289.0M | $96.2M |
总资产PBFSSPRO
| Q4 25 | $2.2B | $68.9M | ||
| Q3 25 | $2.2B | $54.2M | ||
| Q2 25 | $2.1B | $62.1M | ||
| Q1 25 | $2.1B | $77.7M | ||
| Q4 24 | — | $110.5M | ||
| Q3 24 | $2.0B | $135.2M | ||
| Q2 24 | — | $149.9M | ||
| Q1 24 | $2.0B | $167.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.1M | $-8.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 2.97× | -0.26× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PBFSSPRO
| Q4 25 | $11.1M | $-8.4M | ||
| Q3 25 | $3.9M | $17.4M | ||
| Q2 25 | $5.1M | $-17.7M | ||
| Q1 25 | $-3.5M | $-4.0M | ||
| Q4 24 | — | $-23.4M | ||
| Q3 24 | $1.9M | $12.8M | ||
| Q2 24 | $9.0M | $-18.7M | ||
| Q1 24 | $3.3M | $5.9M |
现金转化率PBFSSPRO
| Q4 25 | 2.97× | -0.26× | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | -0.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 2.30× | — | ||
| Q1 24 | 0.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
